Beta Drugs Limited

₹1,806As of Sun 8 Nov 2026, 12:00 UTC
NSE:BETAHealthcare
Country India
PE (Fwd) •••
TSR 9Y CAGR 34.57%
Div yield —
ROE 18.78%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.31)
PE TTM 40.75
TSR TTM (2.65%)
Mkt cap ₹18.31B
ROIC 18.64%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹2,151
19.13%
113.53%
Hold 2|12|5|12|1
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
15.75
15.99
16.45
16.02
4.05%
(0.60%)
3.29%
(2.90%)
Revenue₹B
2.216
2.257
2.348
2.410
8.56%
11.04%
11.31%
8.96%
Peers (US$194.9M)
Cap (US$)
PE
206.5M
15.78x
203.2M
22.59x
Capital
TTM
5Y
10Y
Leveragex
0.718
0.778
0.588
EBIT/Intx
1.175
0.470
0.425
Own earn%
32.52
(97.98)
(73.94)
Sh yield%
37.52
23.77
23.64
Owners
Insiders/Inst%
11.56
49.03
Short interest%
4.99
SBC / revenue%
5.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
7–14
$1 testx
0.3
Incr. ROIC%
12